Cavernous sinus thrombosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence/prevalence of | *The incidence/prevalence of cavernous sinus thrombosis is approximately 1.32–1.57 per 100,000 individuals worldwide.<ref name="pmid27435401">{{cite journal| author=Devasagayam S, Wyatt B, Leyden J, Kleinig T| title=Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study. | journal=Stroke | year= 2016 | volume= 47 | issue= 9 | pages= 2180-2 | pmid=27435401 | doi=10.1161/STROKEAHA.116.013617 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27435401 }} </ref><ref name="pmid29441008">{{cite journal| author=Luo Y, Tian X, Wang X| title=Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review. | journal=Front Aging Neurosci | year= 2018 | volume= 10 | issue= | pages= 2 | pmid=29441008 | doi=10.3389/fnagi.2018.00002 | pmc=5797620 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29441008 }} </ref> | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
*The case-fatality rate/mortality rate of cavernous sinus thrombosis is approximately 20%.<ref name="pmid27781123">{{cite journal| author=Arian M, Kamali A, Tabatabaeichehr M, Arashnia P| title=Septic Cavernous Sinus Thrombosis: A Case Report. | journal=Iran Red Crescent Med J | year= 2016 | volume= 18 | issue= 8 | pages= e34961 | pmid=27781123 | doi=10.5812/ircmj.34961 | pmc=5068248 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27781123 }} </ref> | |||
The combinition of anticoagulants with antibiotics in treatment of cavernous sinus thrombosis has significantly decreased the mortality rate of it.<ref name="pmid24842357">{{cite journal| author=Leo QJ, Bolger DT| title=Septic cavernous sinus thrombosis due to Campylobacter rectus infection. | journal=BMJ Case Rep | year= 2014 | volume= 2014 | issue= | pages= | pmid=24842357 | doi=10.1136/bcr-2013-203351 | pmc=4039913 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24842357 }} </ref> | |||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop | *Patients of all age groups may develop cavernous sinus thrombosis. | ||
*The incidence of | *The incidence of cavernous sinus thrombosis significantly increases with age.<ref name="pmid24842357">{{cite journal| author=Leo QJ, Bolger DT| title=Septic cavernous sinus thrombosis due to Campylobacter rectus infection. | journal=BMJ Case Rep | year= 2014 | volume= 2014 | issue= | pages= | pmid=24842357 | doi=10.1136/bcr-2013-203351 | pmc=4039913 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24842357 }} </ref></ref><ref name="pmid24864625">{{cite journal| author=Karadas S, Milanlioglu A, Gönüllü H, Sayin R, Aydin MN| title=Cerebral venous sinus thrombosis presentation in emergency department in Van, Turkey. | journal=J Pak Med Assoc | year= 2014 | volume= 64 | issue= 4 | pages= 370-4 | pmid=24864625 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24864625 }} </ref> | ||
===Gender=== | ===Gender=== | ||
* | *Women are more commonly affected by cavernous sinus thrombosis than men. The women to men ratio is approximately 3.7–5.3 to 1.<ref name="pmid29441008">{{cite journal| author=Luo Y, Tian X, Wang X| title=Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review. | journal=Front Aging Neurosci | year= 2018 | volume= 10 | issue= | pages= 2 | pmid=29441008 | doi=10.3389/fnagi.2018.00002 | pmc=5797620 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29441008 }} </ref><ref name="pmid24864625">{{cite journal| author=Karadas S, Milanlioglu A, Gönüllü H, Sayin R, Aydin MN| title=Cerebral venous sinus thrombosis presentation in emergency department in Van, Turkey. | journal=J Pak Med Assoc | year= 2014 | volume= 64 | issue= 4 | pages= 370-4 | pmid=24864625 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24864625 }} </ref> | ||
=== | |||
=== | |||
=== | |||
==References== | ==References== | ||
Revision as of 14:56, 28 June 2018
|
Cavernous sinus thrombosis Microchapters |
|
Differentiating Cavernous sinus thrombosis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Cavernous sinus thrombosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Cavernous sinus thrombosis epidemiology and demographics |
|
FDA on Cavernous sinus thrombosis epidemiology and demographics |
|
CDC on Cavernous sinus thrombosis epidemiology and demographics |
|
Cavernous sinus thrombosis epidemiology and demographics in the news |
|
Blogs on Cavernous sinus thrombosis epidemiology and demographics |
|
Risk calculators and risk factors for Cavernous sinus thrombosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamadmostafa Jahansouz M.D.[2]
Overview
Epidemiology and Demographics
Incidence
- The incidence/prevalence of cavernous sinus thrombosis is approximately 1.32–1.57 per 100,000 individuals worldwide.[1][2]
Case-fatality rate/Mortality rate
- The case-fatality rate/mortality rate of cavernous sinus thrombosis is approximately 20%.[3]
The combinition of anticoagulants with antibiotics in treatment of cavernous sinus thrombosis has significantly decreased the mortality rate of it.[4]
Age
- Patients of all age groups may develop cavernous sinus thrombosis.
- The incidence of cavernous sinus thrombosis significantly increases with age.[4]</ref>[5]
Gender
- Women are more commonly affected by cavernous sinus thrombosis than men. The women to men ratio is approximately 3.7–5.3 to 1.[2][5]
References
- ↑ Devasagayam S, Wyatt B, Leyden J, Kleinig T (2016). "Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study". Stroke. 47 (9): 2180–2. doi:10.1161/STROKEAHA.116.013617. PMID 27435401.
- ↑ 2.0 2.1 Luo Y, Tian X, Wang X (2018). "Diagnosis and Treatment of Cerebral Venous Thrombosis: A Review". Front Aging Neurosci. 10: 2. doi:10.3389/fnagi.2018.00002. PMC 5797620. PMID 29441008.
- ↑ Arian M, Kamali A, Tabatabaeichehr M, Arashnia P (2016). "Septic Cavernous Sinus Thrombosis: A Case Report". Iran Red Crescent Med J. 18 (8): e34961. doi:10.5812/ircmj.34961. PMC 5068248. PMID 27781123.
- ↑ 4.0 4.1 Leo QJ, Bolger DT (2014). "Septic cavernous sinus thrombosis due to Campylobacter rectus infection". BMJ Case Rep. 2014. doi:10.1136/bcr-2013-203351. PMC 4039913. PMID 24842357.
- ↑ 5.0 5.1 Karadas S, Milanlioglu A, Gönüllü H, Sayin R, Aydin MN (2014). "Cerebral venous sinus thrombosis presentation in emergency department in Van, Turkey". J Pak Med Assoc. 64 (4): 370–4. PMID 24864625.